Status:
COMPLETED
Levetiracetam in Central Pain in Multiple Sclerosis(MS)
Lead Sponsor:
Odense University Hospital
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Multiple sclerosis is often associated with pain. There is no standard treatment of this type of pain. Levetiracetam is a new anticonvulsant and it is the hypothesis that it could relieve central pain...
Eligibility Criteria
Inclusion
- ms diagnosis verified
- age \> 18 years
- central pain symptoms for more than 3 months
- central pain diagnosis confirmed by neurological examination
- adequate anticonceptive treatment for women with child bearing potential
- informed consent
- baseline pain of more than 4 on numeric rating scale
Exclusion
- other cause of pain
- previous allergic reaction towards levetiracetam
- known adverse drug reaction on levetiracetam
- pregnancy
- severe disease
- inability to follow study protocol
- treatment with antidepressants, other anticonvulsants or opioids
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00423527
Start Date
January 1 2007
End Date
January 1 2009
Last Update
December 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, Odense University Hospital
Odense C, Denmark, DK-5000